Subconjunctival injection of novel antioxidant nanoparticles inhibits neovascularization after corneal injury

Key Points

• The research aims to explore the effectiveness of BP@CS nanoparticles in regulating reactive oxygen species to treat corneal neovascularization.
• Local subconjunctival injection of BP@CS nanoparticles
• Assessment of neovascularization levels after corneal injury
• Evaluation of reactive oxygen species regulation
• Successful reduction of neovascularization observed after treatment with nanoparticles
• Sustained regulation of reactive oxygen species was achieved
• Demonstrated potential for a new therapeutic approach in corneal injuries